Allogeneic bone marrow transplantation for hypereosinophilic syndrome with advanced myelofibrosis
- 1 April 1997
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 19 (7) , 741-743
- https://doi.org/10.1038/sj.bmt.1700729
Abstract
A 33-year-old man with an atypical course of hypereosinophilic syndrome including malignant hypercalcemia, osteolytic lesions and evolution into severe myelofibrosis was treated by allogeneic bone marrow transplantation after conditioning with cytoxan and total body irradiation. As the transplant was sex-mismatched, chimerism was studied by means of cytogenetic analysis and Y chromosomal DNA amplification by PCR assay. Long-term complete remission has been assessed by normalization of blood cell counts, magnetic resonance imaging and karyotypic analysis. A relapse was observed 40 months after transplantation. The patient remains alive 44 months post-BMT. This case report is compared with those reported in the literature.Keywords
This publication has 0 references indexed in Scilit: